Literature DB >> 11869698

Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer.

William E Burak1, Scott T Hollenbeck, Emmanuel E Zervos, Karen L Hock, Lisa C Kemp, Donn C Young.   

Abstract

BACKGROUND: This study was designed to compare the postoperative morbidity and socioeconomic impact of sentinel lymph node biopsy (SLNB) with axillary lymph node dissection (ALND) in patients with early stage breast cancer.
METHODS: A prospective, nonrandomized, controlled study was designed to include patients who underwent breast conservation surgery and SLNB +/- ALND. Group A consisted of patients who had a negative SLNB and did not go on to completion ALND. Group B consisted of patients who underwent a SLNB followed by a completion ALND because either (1) their sentinel node contained cancer or (2) they were within the validation phase of our institution's sentinel lymph node protocol. Patients were evaluated with a questionnaire and underwent a standardized physical examination to determine arm circumference.
RESULTS: Data were obtained from 96 patients with a mean follow-up period of 15 months (range 8 to 29). Significant differences were seen in subjective measurements of arm complaints and arm numbness (P <0.001), with fewer complaints reported in group A. The difference in mid-bicep and antecubital fossa circumferences was significant when comparing the ratio of the procedure arm with the nonprocedure arm and when subtracting the nonprocedure arm from the procedure arm (P <0.003 and P <0.016, respectively) in favor of group A. Axillary surgery was performed as an outpatient procedure in 88% of group A patients, compared with 15% in group B (P <0.001). Furthermore, 71% of group A patients returned to "normal activity" in less than 4 days, in comparison with 7% of group B (P <0.001).
CONCLUSIONS: SLNB results in less postoperative morbidity in terms of subjective arm complaints and mid-arm swelling. Expeditious return to work or normal activity after SLNB has potentially significant socioeconomic consequences.

Entities:  

Mesh:

Year:  2002        PMID: 11869698     DOI: 10.1016/s0002-9610(01)00848-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  35 in total

1.  Perceptions of upper-body problems during recovery from breast cancer treatment.

Authors:  Louisa G Collins; Robyn Nash; Tracey Round; Beth Newman
Journal:  Support Care Cancer       Date:  2003-10-31       Impact factor: 3.603

2.  Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer.

Authors:  Allan W Silberman; Carie McVay; Jason S Cohen; Jack F Altura; Sandra Brackert; Gregory P Sarna; Daphne Palmer; Albert Ko; Leslie Memsic
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

3.  Return to work in low-income Latina and non-Latina white breast cancer survivors: a 3-year longitudinal study.

Authors:  Victoria S Blinder; Sujata Patil; Amardeep Thind; Allison Diamant; Clifford A Hudis; Ethan Basch; Rose C Maly
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

4.  Subdermal re-injection: a method to increase surgical detection of the sentinel node in breast cancer without increasing the false-negative rate.

Authors:  M T Bajén; A Benítez; J Mora; Y Ricart; N Ferran; S Guirao; D Carrera; M Gil; M J Pla; A Gumá; J A Palacin; J Martin-Comin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-11-24       Impact factor: 9.236

Review 5.  Contemporary quality of life issues affecting gynecologic cancer survivors.

Authors:  Jeanne Carter; Richard Penson; Richard Barakat; Lari Wenzel
Journal:  Hematol Oncol Clin North Am       Date:  2011-12-16       Impact factor: 3.722

6.  A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection.

Authors:  Jan J Kootstra; Josette E H M Hoekstra-Weebers; Johan S Rietman; Jakob de Vries; Peter C Baas; Jan H B Geertzen; Harald J Hoekstra
Journal:  Ann Surg Oncol       Date:  2010-03-11       Impact factor: 5.344

Review 7.  Sentinel lymph node biopsy progress in surgical treatment of cancer.

Authors:  T Schulze; A Bembenek; P M Schlag
Journal:  Langenbecks Arch Surg       Date:  2004-06-09       Impact factor: 3.445

8.  Surgical site infection among women discharged with a drain in situ after breast cancer surgery.

Authors:  Wilza Andrade Barbosa Felippe; Guilherme Loureiro Werneck; Guilherme Santoro-Lopes
Journal:  World J Surg       Date:  2007-12       Impact factor: 3.352

9.  The impact of mammographic screening on the surgical management of breast cancer.

Authors:  Ted A James; Jacqueline E Wade; Brian L Sprague
Journal:  J Surg Oncol       Date:  2016-01-22       Impact factor: 3.454

10.  Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer.

Authors:  Keiichiro Tada; Akiko Ogiya; Kiyomi Kimura; Hidetomo Morizono; Kotaro Iijima; Yumi Miyagi; Seiichiro Nishimura; Masujiro Makita; Rie Horii; Futoshi Akiyama; Takuji Iwase
Journal:  World J Surg Oncol       Date:  2010-01-27       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.